JamesAlanKnutsonMD

Psychiatry • Everett, WA

Addiction, Child & Adolescent Psychiatry, Psychopharmacology

Physician

Join to view full profile

Dr. Knutson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Knutson's full profile

Already have an account?

Office
2918 Colby Ave
Suite 101
Everett, WA 98201
Phone+1 425-443-9551

Fax+1 425-610-4413

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Child and Adolescent Psychiatry, 1993 - 1995
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Psychiatry, 1990 - 1993
University of Washington School of MedicineClass of 1990

Certifications & Licensure

CA State Medical License 2018 - 2025
WA State Medical License 1996 - 2025
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia Start of enrollment: 2011 Jul 01
Completed
Phase 3
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
Completed
Phase 3
PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01
Completed
Phase 3
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01
Completed
Phase 3
Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Jun 18
Completed
Phase 3
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Nov 19
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Safety and Efficacy of Brexpiprazole in the Treatment of Irritability Associated with Autism Spectrum Disorder: An 8-Week, Phase 3, Randomized, Double-Blind, Placebo-C...
Caroline Ward, Ann Childress, Krista Martinko, Dalei Chen, Klaus Groes Larsen
Journal of Child and Adolescent Psychopharmacology. 2025-02-19
9 citations
A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder.
Jeffrey R Strawn, Leslie Moldauer, Rebekah D Hahn, Alexandria Wise, Kristina Bertzos
Journal of Child and Adolescent Psychopharmacology. 2023-04-01